tpst1120,nivolumab,bevacizumab,atezolizumab
medsir,roche,bms,tempest therapeutics
['nivo', 'tpst-1120 ', 'hcc', 'beva', 'bevacizumab', 'atezo', 'medsir']
great presentation on tpst-1120 as a single agent or in combo w/ nivo - tolerable safety
- disease control as monotherapy &amp; promising response in combo w/ nivo next step combo of tpst-1120+ atezolizumab +bevacizumab vs. atezolizumab+bevacizumab in 1lhcc
#asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc